A Phase II Study of Epigenetic Therapy to Overcome Chemotherapy Resistance in Refractory Solid Tumors

Clinical trial NCT00404508 · COMPLETED

Trial details

NCT number: NCT00404508
Sponsor: National Institute of Cancerología
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Refractory Solid Tumors

Start date: 2005-09-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.